|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 295/08 | |
| C07D 207/26 | |||
| C07C 229/12 | |||
| A61K 31/40 | |||
| A61K 31/195 |
| (11) | Number of the document | 1268453 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01912069.0 |
| Date of filing the European patent application | 2001-03-19 | |
| (97) | Date of publication of the European application | 2003-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2006-07-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2001/000427 |
| Date | 2001-03-19 |
| (87) | Number | WO 2001/077093 |
| Date | 2001-10-18 |
| (30) | Number | Date | Country code |
| 267198 P | 2000-04-07 | US |
| (72) |
DAY, W. W. Pfizer Global Res. & Development, US
JOHNSON, K. A. Pfizer Global Res. & Development, US
PRAKASH, C. A. Pfizer Global Res. & Development, US
EGGLER, J. F. Pfizer Global Res. & Development, US
|
| (73) |
Pfizer Products Inc.,
Eastern Point Road, Groton, CT 06340,
US
|
| (54) | ESTROGEN AGONIST/ANTAGONIST METABOLITES |
| ESTROGEN AGONIST/ANTAGONIST METABOLITES |